首页> 美国卫生研究院文献>Pharmacy: Journal of Pharmacy Education and Practice >A Primer on Quality Assurance and Performance Improvement for Interprofessional Chronic Kidney Disease Care: A Path to Joint Commission Certification
【2h】

A Primer on Quality Assurance and Performance Improvement for Interprofessional Chronic Kidney Disease Care: A Path to Joint Commission Certification

机译:专业间慢性肾脏病护理质量保证和性能改进入门:通往联合委员会认证的途径

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Interprofessional care for chronic kidney disease facilitates the delivery of high quality, comprehensive care to a complex, at-risk population. Interprofessional care is resource intensive and requires a value proposition. Joint Commission certification is a voluntary process that improves patient outcomes, provides external validity to hospital administration and enhances visibility to patients and referring providers. This is a single-center, retrospective study describing quality assurance and performance improvement in chronic kidney disease, Joint Commission certification and quality outcomes. A total of 440 patients were included in the analysis. Thirteen quality indicators consisting of clinical and process of care indicators were developed and measured for a period of two years from 2009–2017. Significant improvements or at least persistently high performance were noted for key quality indicators such as blood pressure control (85%), estimation of cardiovascular risk (100%), measurement of hemoglobin A1c (98%), vaccination (93%), referrals for vascular access and transplantation (100%), placement of permanent dialysis access (61%), discussion of advanced directives (94%), online patient education (71%) and completion of office visit documentation (100%). High patient satisfaction scores (94–96%) are consistent with excellent quality of care provided.
机译:慢性肾脏病的跨专业护理有助于向复杂的高危人群提供高质量,全面的护理。专业间护理是资源密集型的,需要价值主张。联合委员会认证是一种自愿程序,可以改善患者的病情,为医院管理提供外部有效性,并提高患者和推荐医疗人员的知名度。这是一项单中心回顾性研究,描述了慢性肾脏病的质量保证和性能改善,联合委员会认证和质量结果。分析中总共包括440位患者。在2009-2017年的两年中,制定并测量了包括临床和护理过程指标在内的13项质量指标。关键的质量指标,如血压控制(85%),心血管风险评估(100%),血红蛋白A1c的测量(98%),疫苗接种(93%),转诊,血管通路和移植(100%),放置永久性透析通路(61%),高级指令讨论(94%),在线患者教育(71%)以及完成就诊记录(100%)。较高的患者满意度评分(94-96%)与提供的优质护理相一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号